ARMISTICE CAPITAL, LLC VRCA β€” VERRICA PHARMACEUTICALS INC

Ownership history in ARMISTICE CAPITAL, LLC  Β·  5 quarters on record

AI Ownership Summary

ARMISTICE CAPITAL, LLC reported VERRICA PHARMACEUTICALS INC (VRCA) in 5 quarterly 13F filings from 2024 Q4 through 2025 Q4. Peak portfolio weight reached 0.11% in 2025 Q4. The latest visible filing shows VRCA at 0.11% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this VRCA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was ARMISTICE CAPITAL, LLC's position in VERRICA PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

VRCA was reported at 0.11% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.11% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

VRCA stock page ARMISTICE CAPITAL, LLC fund profile ARMISTICE CAPITAL, LLC full holdings
How ARMISTICE CAPITAL, LLC held VRCA β€” position size vs. price
% of Fund (quarterly)    VRCA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
πŸ“‹ Quarterly Holdings History 5 quarters  β–Ύ
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED β€” β€” β€” 1,118,925 +479,732 +75.1% 0.11% $9.3M 2026-02-14 (Est.) $5.69
2025 Q3 REDUCED 92.8% +90.3% ❌ 639,193 -8,242,151 -92.8% 0.04% $2.8M 2025-11-17 $3.73
2025 Q2 ADDED β€” β€” β€” 8,881,344 +313,944 +3.7% 0.08% $4.7M 2025-08-14 $6.15
2025 Q1 REDUCED β€” β€” β€” 8,567,400 -353,600 -4.0% 0.06% $3.8M 2025-05-15 $6.42
2024 Q4 INITIATED β€” β€” β€” 8,921,000 β€” β€” 0.09% $6.2M 2025-02-14 $7.37

🏒 Other funds also holding VRCA

As of 2026 Q1 β€” sorted by position size

New England Capital Financial Advisors LLC 3Y 0.0% Fortitude Family Office, LLC 0.0%

FAQ About ARMISTICE CAPITAL, LLC and VRCA

These are the practical questions this page is built to answer before you even open the full history table.

How long has ARMISTICE CAPITAL, LLC reported owning VRCA?

ARMISTICE CAPITAL, LLC reported VRCA across 5 quarterly 13F filings, from 2024 Q4 through 2025 Q4.

What was the largest reported VRCA position in ARMISTICE CAPITAL, LLC's portfolio?

The largest reported portfolio weight for VRCA was 0.11% in 2025 Q4.

What is the latest reported VRCA position on this page?

The most recent filing on this page is 2025 Q4, when ARMISTICE CAPITAL, LLC reported 1,118,925 shares, equal to 0.11% of portfolio, with an estimated market value of $9.3M.

What does the chart on this VRCA ownership page compare?

The chart compares ARMISTICE CAPITAL, LLC's quarterly VRCA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did ARMISTICE CAPITAL, LLC time their VRCA position?

Based on 13F filing dates vs. subsequent VRCA price moves, ARMISTICE CAPITAL, LLC correctly timed 1 out of 4 reported position changes (25%). The annualised alpha on VRCA relative to SPY over the holding period was -31.8%.

← Back to ARMISTICE CAPITAL, LLC Holdings